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LETTERS
GI JEV isolates from India share 
close genetic relationship with GI 
strains from Japan and Korea. In In-
dia, JEV neutralizing antibodies have 
been detected in 179 (34.8%) of 514 
birds, including pond herons and cat-
tle egrets, indicating a possible role in 
virus maintenance (9). Large perenni-
al lakes, swamps, and rice ﬁ  elds pro-
vide a wintering and staging ground 
for several migratory waterfowl; such 
areas also favor breeding and survival 
of mosquitoes (10). Considering these 
conditions, GI JEV may have been in-
troduced into India through migratory 
birds, as it has in other Asian countries 
(5). However, the exact mode of in-
troduction of GI JEV into India is not 
known, and further studies are needed 
to determine the role of migratory 
birds in JE transmission.
This study suggests the recent in-
troduction of JEV GI strain in India. 
Simultaneous detection of GI and GIII 
strains indicates their co-circulation 
and association with human infections 
in Gorakhpur region. Because the live 
attenuated JE vaccine used in India is 
derived from GIII strain SA14–14–2, 
the efﬁ  cacy of the vaccine to protect 
against GI JEV must be carefully eval-
uated. Thus, the genetic and antigenic 
variation among JEV strains circulat-
ing in India should be monitored to 
determine effects on JE epidemiology 
and ongoing vaccination efforts. Addi-
tionally, the expansion of GI JEV into 
other parts of India should be continu-
ously tracked.
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Dengue Virus 
Serotype 3 
Subtype III, 
Zhejiang Province, 
China
To the Editor: Beginning in July 
2009, physicians in the city of Yiwu, 
Zhejiang Province, People’s Republic 
of China, noted an outbreak of illness 
characterized by rash, headache, sub-
jective fever, itching, anorexia, and 
arthritis. We present the results of the 
investigation of this outbreak, which 
was caused by dengue virus (DENV) 
serotype 3 (DENV-3) subtype III.
DENV-3 subtype III has been 
continuously circulating in the Indian 
subcontinent since the 1960s. The vi-
rus was ﬁ  rst isolated from East Africa 
in 1985 in Mozambique and subse-
quently in Kenya (1991) and Somalia 
(1993) (1,2). Although dengue has 
occurred frequently in southern Chi-
na, including Guangdong, Guangxi, 
Hainan, Fujian, and Zhejiang Prov-
inces and in Taiwan (3–6), to our 
knowledge, DENV-3 subtype III has 
not been reported in China.
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Yiwu is in the center of Zheji-
ang Province, southeastern China. 
This investigation included the entire 
town of Yiwu and towns that are part 
of the larger town of Yiting where the 
outbreak took place. We reviewed 
medical records and conducted pro-
spective surveillance at all hospitals, 
health centers, and outpatient clinics 
in Yiwu to identify patients with sus-
pected dengue fever (DF) during July 
1 through October 31, 2009. Accord-
ing to the diagnostic criteria for DF 
(WS216–2008) enacted by the Chi-
nese Ministry of Health, a patient with 
suspected disease had at least 2 of the 
following symptoms: acute onset of 
rash, headache, subjective fever, itch-
ing, anorexia, or arthralgia. Patients 
with suspected disease were asked to 
provide blood specimens during the 
acute phase (within 7 days after symp-
tom onset).
Serum samples were tested by 
ELISA for immunoglobulin (Ig) 
M against DENV by using the E-
DEN01M kit (Panbio, Sinnamon Park, 
Queensland, Australia). Acute-phase 
serum samples were tested by real-
time PCR for DENV RNA, according 
to the diagnostic criteria for dengue 
fever enacted by the Chinese Ministry 
of Health. Samples that were positive 
for DENV-3 by real-time PCR were 
inoculated into Aedes albopictus mos-
quito clone C6/36. Primers for reverse 
transcription–PCR and sequencing of 
the envelope gene of DENV isolates 
were used to identify DENV (4).
We considered a patient to have a 
conﬁ  rmed case if DENV RNA was de-
tected in the serum by real-time PCR 
or if IgM against DENV was present. 
A patient was considered to have a 
clinically diagnosed case if he or she 
had acute onset of rash, headache, 
subjective fever, itching, anorexia, 
and leukopenia, and lived in Qingsu, 
Fantianzhu, Xitian, or Shangzhai (4 
adjoining villages in the area of the 
ﬁ  rst conﬁ  rmed case). 
The sequences of isolates from 
case-patients were compared with 
published sequences by using the 
BLAST program (www.ncbi.nlm.nih.
gov/BLAST/), and phylogenic analy-
sis was calculated with PAUP 4.0 β 10 
(7), which ran an unrooted tree with 
1,000 bootstrap replicates.
We identiﬁ   ed 196 cases of DF; 
279 suspected cases were excluded, 
and no cases of dengue hemorrhagic 
fever or dengue shock syndrome were 
found. Of DF cases, 71 (36.2%) were 
conﬁ  rmed and 125 (63.8%) were clin-
ically diagnosed. Acute-phase serum 
samples were collected within 7 days 
after the onset of illness from 350 pa-
tients with suspected DF, and dengue 
virus RNA was detected in samples 
from 65 patients (18.6%). Six samples 
had IgM against DENV.
Twenty-six samples positive for 
DENV RNA by real-time PCR were 
randomly selected to isolate viruses; 
23 isolates were cultured. All isolates 
were ampliﬁ  ed by reverse transcrip-
tion–PCR, and amplicons were se-
quenced. The envelope gene sequenc-
es of all isolates were identical and 
1,479 nt in length. All sequences had 
99% similarity to 1 DENV serotype 3 
partial envelope gene (GenBank ac-
cession no. AM746229), which had 
been detected in Jeddah, Saudi Ara-
bia, in 2004. According to evolution-
ary analysis (Figure), sequences of our 
study were also most closely related to 
the isolate from Saudi Arabia, which 
suggests that the outbreak may have 
been initiated by imported cases from 
the Indian subcontinent or western 
Asia.
The date of symptom onset among 
patients with conﬁ  rmed or clinically 
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Figure. Evolutionary analysis of dengue virus isolates from this study (boldface) compared 
with established dengue virus serotype 3 subtypes, Zhejiang Province, People’s Republic 
of China, 2009.
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diagnosed cases ranged from July 20 
to October 4, 2009. Cases peaked in 
early September and subsided in early 
October. The median age of patients 
with conﬁ   rmed or probable disease 
was 47.3 years (range 3–96 years). 
Infections occurred in all age groups, 
but most infections occurred among 
persons 41 to 65 years of age; 118 
(60.2%) were women, and 172 were 
farm workers. 
Conﬁ   rmed and clinically diag-
nosed cases occurred in 18 villages, 
which were part of 7 towns. Most 
cases (182) were reported in Yiting, 
where the ﬁ   rst case was conﬁ  rmed, 
and in particular, were in persons who 
lived in the villages of Qingsu, 100 
cases; Fantianzhu, 49 cases; Xitian, 
19 cases; Shangzhai, 4 cases; and Xi-
ateng, 4 cases.
The outbreak shows that DENV-3 
subtype III is easily transmitted among  
humans and mosquitoes and can adapt 
efﬁ  ciently to a new area. Other coun-
tries where the climate is similar to 
that of Zhejiang Province (subtropical 
monsoon) should be aware of the risk 
for expansion of DENV-3 subtype III 
transmission. Clinical vigilance and 
strong epidemiologic and laboratory 
surveillance are essential. 
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European Subtype
Tick-borne 
Encephalitis Virus 
in Ixodes 
persulcatus Ticks
To the Editor: The northernmost 
tick-borne encephalitis (TBE) focus is 
in Simo, Finnish Lapland. Four TBE 
cases were conﬁ   rmed during 2008–
2009. Tick-borne encephalitis virus 
(TBEV) is transmitted by Ixodes spp. 
ticks and is endemic to Eurasia from 
central Europe to the Far East. The vi-
rus has 3 subtypes: European (TBEV-
Eur), Siberian (TBEV-Sib), and Far 
Eastern (TBEV-FE). TBEV-Eur is 
mainly transmitted by I. ricinus ticks 
(sheep ticks) and the 2 other subtypes 
by  I. persulcatus ticks (taiga ticks). 
The range of I. ricinus ticks covers 
most of continental Europe and the 
British Isles; I. persulcatus ticks are 
distributed throughout eastern Europe 
and Asia to the People’s Republic of 
China and Japan.
The transmission cycle of at least 
TBEV-Eur in nature is fragile and de-
pends on microclimatic conditions. 
Thus, within the I. ricinus distribution 
area, TBE is endemic merely focally 
(1,2). In Finland, TBE foci are lo-
cated by the sea or large lakes (online 
Appendix Figure, www.cdc.gov/EID/
content/17/2/321-appF.htm). Both vec-
tor tick species are found: I. ricinus 
ticks in the southern and central parts 
of the country, but I. persulcatus ticks 
are in scattered foci along the western 
coast, including the Kokkola archipel-
ago and Närpiö municipality, where 
they carry TBEV-Sib (3,4) (online Ap-
pendix Figure).
The ﬁ  rst human TBE cases from 
Simo in Lapland (65°40′N, 24°54′E; 
online Appendix Figure) were re-
ported during 2008 (n = 2) and 2009 
(n = 2). On the basis of interviews with 
the 2 patients from 2008, we collected 
97 ticks and 17 bank voles from the 2 
probable sites of infection during June 
2009. From the rodents, we extracted 
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